Rate of drug-resistant Streptococcus pneumoniae in children with invasive pneumococcal disease: a decade review
Keywords:
reptococcus pneumoniae, pneumococcal diseaseAbstract
Background: Streptococcus pneumoniae is a common causative organism of pneumonia, bacteremia and meningitis in children. Rate of drug-resistant Streptococcus pneumoniae (DRSP) is an important information to guide appropriate empirical antibiotics.
Objectives: This study aimed to describe rates of DRSP and clinical outcomes of patients with invasive pneumococcal disease (IPD).
Methods: A retrospective study was conducted among pediatric patients with IPD from 2008 -2017. DRSP was defined as National Committee for clinical laboratory standards guidelines 2013.
Results: From January 2008 to December 2017, 71 patients with diagnosis of IPD were identified. Median (interquartile range) age was 2 years (2 months - 15 years 2 months). Forty-seven patients (66.0%) had underlying diseases, the most was congenital heart diseases (15.0%). There were 25 patients with bacteremia with or without localized infection and 46 patients with pneumonia. Proportion of penicillin-resistant S. pneumoniae (PRSP) infection increased from 17.5% (95% CI 7.4 - 32.8) during 2008 - 2012 to 25.8% (95% CI 11.9 - 44.6) during 2013 - 2017 (P - value = 0.39). Third generation cephalosporins-resistant S. pneumoniae infection was stable during the two time periods, which was 5.0% (95% CI 1.0 - 16.9) during 2008 - 2012 and 3.2% (95% CI 0.1 - 16.7) during 2013 - 2017 (P - value = 0.71). The common empirical antibiotics treatment included third generation cephalosporins (79.0%), meropenem (8.0%), third generation cephalosporins plus vancomycin (4.0%) and others (9.0%). Only one patient died from bacteremia with sepsis directly related to IPD.
Conclusion: There is an increasing trend of PRSP over the past decade but not to the extent of third generation cephalosporins-resistant. Therefore, third generation cephalosporins stand as a good option for IPD empirical treatment.
Downloads
References
Kimberlin DW, Brady MT, Jackson MA, Long SS. Red Book: Report of the Committee on Infectious Diseases. 30th ed. American Academy of Pediatrics: Illinois; 2015.
O'Brien KL, Wolfson LJ, Watt JP, Henkle E, DeloriaKnoll M, McCall N et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009;374:893-902.
https://doi.org/10.1016/S0140-6736(09)61204-6
Rhodes J, Dejsirilert S, Maloney SA, Jorakate P, Kaewpan A, Salika P, et al. Pneumococcal bacteremia requiring hospitalization in rural Thailand: An update on incidence, clinical characteristics, serotype distribution, and antimicrobial susceptibility, 2005- 2010. Plos One 2013;8:e66038.
https://doi.org/10.1371/journal.pone.0066038
Pancharoen C, Chongthaleong A, Reinprayoon S. Invasive pneumococcal infection and drug-resistant Streptococcus pneumoniae in Thai children. J Med Assoc Thai 2001;84:1246-50.
Finkelstein JA, Huang SS, Daniel J, Rifas-Shiman SL, Kleinman K, Goldmann D, et al. Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample. Pediatrics 2003;122:862-9.
https://doi.org/10.1542/peds.112.4.862
Bautista A, Richardson V, Ortiz-orozco O, Luna-Cruz ME, Carnalla-Barajas MN, Echaniz-Aviles G, et al. Prevalence of pneumococcal disease, serotype distribution and antimicrobial susceptibility in Mexican children younger than 5 years of age. Arch Med Res 2012;44:142-50.
https://doi.org/10.1016/j.arcmed.2012.12.005
Phongsamart W, Srifeungfung S, Chatsuwan T, Nunthapisud P, Treerauthaweeraphong V, Rungnobhakhun P, et al. Changing trends in serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive diseases in Central Thailand, 2009-2012. Hum Vaccin Immunother 2014;10:1866-73. https://doi.org/10.4161/hv.28675
Sader HS, Mendes RE, Le J, Denys G, Flamm RK, Jones RN. Antimicrobial susceptibility of Streptococcus pneumoniae from North America, Europe, Latin America, and the Asia-Pacific Region: results from 20 years of the SENTRY antimicrobial surveillance program (1997 - 2016). Infect Dis 2019;15:S14-S23.
https://doi.org/10.1093/ofid/ofy263
Tam PI, Thielen BK, Obaro SK, Brearley AM, Kaizer AM, Chu H, et al. Childhood Pneumococcal Disease in Africa - A systemic review and meta-analysis of incidence, serotype distribution, and antimicrobial susceptibility. Vaccine 2017;35:1817-27. https://doi.org/10.1016/j.vaccine.2017.02.045
Ricketson LJ, Conradi NG, Vanderkooi OG. Changes in the nature and severity of invasive pneumococcal disease in children before and after the seven-valent and thirteen-valent pneumococcal conjugate vaccine programs in Calgary, Canada. Pediatr Infect Dis J 2018; 37:22-7.
https://doi.org/10.1097/INF.0000000000001709
Gomez-Barreto D, Calderon-Jaimes E, Rodriguez RS, Delos Monteros LE. Clinical outcome of invasive infections in children caused by highly penicillin resistant Streptococcus pneumoniae compared with infections caused by penicillin-susceptible strains. Arch Med Res 2000;31:592-8.
https://doi.org/10.1016/S0188-4409(00)00244-7
Techasaensiri C, Messina A, Katz Kathy. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19a in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas. Pediatr Infect Dis J 2010;29:519-23.
https://doi.org/10.1097/INF.0b013e3181cdafc2
Kim SH, Song JH, Chung DR, Thamlikitkul V, Yang YH, Wang H, et al. Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian network for surveillance of resistant pathogens (ANSORP) study. Antimicrob Agents Chemother 2012;56:1418-26.
https://doi.org/10.1128/AAC.05658-11
Song JH, Jung SI, Ko KS. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae Isolates in Asia (an ANSORP Study). Antimicrob Agents Chemother 2004;48:2101-7.
https://doi.org/10.1128/AAC.48.6.2101-2107.2004
National antimicrobial resistance surveillance center, Thailand [Internet]. 2019 [cited 2019 Dec 10]. Available from: http://narst.dmsc.moph.go.th
Suankratay C, Techawaleekul P, Suwanpimolkul G. Infections caused by drug-resistant Streptococcus pneumoniae at King Chulalongkorn Memorial Hospital, Thailand. J Infect Dis Antimicrob Agents 2010;27:160.
Rattanaumpawan P, Chaiwarith R, Supparatpinyo K. Prevalence of penicillin-resistant Streptococcus pneumoniae (PRSP) infection at Maharaj Nakorn Chiang Mai Hospital. J Infect Dis Antimicrob Agents 2015;22:93-101.
Sangthawan P, Chantaratchada S, Chanthadirai N, Wattanathum A. Prevalence and clinical significance of community-acquired penicillin-resistant pneumococcal pneumonia in Thailand. Respirology 2003;8:208-12. https://doi.org/10.1046/j.1440-1843.2003.00444.x
Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: 18th Informational Supplement. CLSI Publication No. M100-S23. Wayne PA: Clinical and Laboratory Standard Institute; 2013.
Chotpitayasunondh T. Clinical practice guideline of acute meningoencephalitis [Internet]. Bangkok: Pediatric Infectious Disease Society of Thailand; 2014 [cited 2019 Nov 11]. Available from: http://www.pidst.net
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Chulalongkorn Medical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
